Indivior (INDV)

Sector:

Pharma and Biotech

Index:

FTSE 250

209.80p
   
  • Change Today:
      2.20p
  • 52 Week High: 213.69p
  • 52 Week Low: 94.55p
  • Currency: UK Pounds
  • Shares Issued: 725.54m
  • Volume: 1,986,073
  • Market Cap: £1,522.19m
  • RiskGrade: 314

Indivior Overview

Indivior is a pharmaceutical company specialising in addiction treatment. Indivior was spun out of parent Reckitt Benckiser in December 2014. Adding to its Suboxone opioid addiction product, the company has a pipeline including longer-lasting 'depot' formulations, treatments for cocaine intoxication, alcohol addiction and even schizophrenia, as a psychiatric co-morbidity of addiction.

Key Personnel

CEO: Mark Crossley
CFO & Executive Director: Ryan Preblick
Chairman: Graham Hetherington
Company Secretary: Kathryn Hudson
Independent Non-Executive Director: Jo Le Couilliard
Independent Non-Executive Director: A. Thomas McLellan
Independent Non-Executive Director: Mark Stejbach
Independent Non-Executive Director: Lorna Parker
Independent Non-Executive Director: Juliet Thompson
Independent Non-Executive Director: Peter Bains
Senior Independent Director: Daniel J. Phelan
Non-Executive Dir: Jerome Lande

Contact Details

Address: 234 Bath Road, Slough, Berkshire, United Kingdom, SL1 4EE
Website: http://www.Indivior.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE 250FTSE 350FTSE All-Share
Overseas Listings: BATSLON:INDVL
ISIN: GB00BRS65X63

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Indivior Market Data

Currency UK Pounds
Share Price 209.80p
Change Today 2.20p
% Change 1.06 %
52 Week High 213.69p
52 Week Low 94.55p
Volume 1,986,073
Shares Issued 725.54m
Market Cap £1,522.19m
RiskGrade 314

Indivior Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
38.38% below the market average38.38% below the market average38.38% below the market average38.38% below the market average38.38% below the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average
Price Trend
94.95% above the market average94.95% above the market average94.95% above the market average94.95% above the market average94.95% above the market average
93.55% above the sector average93.55% above the sector average93.55% above the sector average93.55% above the sector average93.55% above the sector average
Income Not Available
Growth
68.96% below the market average68.96% below the market average68.96% below the market average68.96% below the market average68.96% below the market average
83.33% below the sector average83.33% below the sector average83.33% below the sector average83.33% below the sector average83.33% below the sector average

What The Brokers Say

Strong Buy 3
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 3
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Indivior Dividends

No dividends found

Trades for 20-Sep-2021

Time Volume / Share Price
16:35 9,706 @ 209.80p
16:35 18,003 @ 209.80p
16:35 475,903 @ 209.80p
16:29 26 @ 209.20p
16:29 275 @ 209.33p

Indivior Key Personnel

CEO Mark Crossley
Chair Graham Hetherington

Top of Page